Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study)
Published: 10 February 2022| Version 1 | DOI: 10.17632/8wvxff49g8.1
Contributors:
, , , , , , , , , , , , , , , , , , , , , , , Description
DOI: 10.1002/ccd.29683 Patients with cardiogenic shock and concomitant severe mitral regurgitation have high mortality rates. This study evaluated the procedural safety and efficacy at short and mid-term of edge-to-edge percutaneous mitral valve repair (PMVR) in this setting. We found that edge-to-edge PMVR had an acceptable complication rate and procedural success was a predictor of both 30-day and 6-month survival. We concluded that edge-to-edge PMVR is a safe and effective procedure in patients with severe mitral regurgitation complicating cardiogenic shock and could be considered a bailout option in this setting.
Files
Steps to reproduce
Please refer to the publication details
Institutions
Ospedale San Raffaele, Universita Vita Salute San Raffaele
Categories
Shock, Mitral Valve Disease, Mitral Valve Surgery, Circulation Support, Percutaneous Valve, Transcatheter Therapy